EVA is a non-profit biobank, distributing viruses and derived products, and giving access to a range of services
Around 25% of our end-users come from the industrial sector. We offer a dedicated Industrial Platform to make the bridge between our products and your industrial applications:
- Accessible to members only
- Pre-negociated MTAs for different range of uses (diagnostic tests R&D, antiviral drug R&D, vaccine R&D, Internal research…)
- A dedicated team for managing your orders
- Pre-warning of new products release based on your interests
Accesses to our biobank
- Free of charge access to derived material (SMEs only)
- Access to technical platform and services:
- validation of diagnostics kits
- validation of antivirals (in vitro, in vivo)
- sequencing platforms
- access to BSL3- BSL4 facilities in 13 countries
- Access to tailor made material:
- recombinant proteins
- nanobodies
- reverse genetics systems
- positive controls and PCR probes
- Design of dedicated training programs and workshops
Access to the EVA network of virologists worldwide
- Specific biobanks not available on the catalogue
- Special cell lines
- Know-how & scientific collaboration
- Lobbying activities aiming at finding extra funding to develop industrial projects